JOHNSON INVESTMENT COUNSEL INC - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
JOHNSON INVESTMENT COUNSEL INC ownership history of GLOBUS MED INC
ValueSharesWeighting
Q3 2023$409,265
-34.9%
8,243
-21.9%
0.01%
-37.5%
Q2 2023$628,802
-10.4%
10,561
-14.8%
0.01%
-11.1%
Q1 2023$702,109
-79.5%
12,396
-73.2%
0.01%
-80.9%
Q4 2022$3,430,308
+39.9%
46,187
+12.2%
0.05%
+30.6%
Q3 2022$2,452,000
+6.5%
41,167
+0.4%
0.04%
+9.1%
Q2 2022$2,302,000
-24.1%
40,998
-0.3%
0.03%
-13.2%
Q1 2022$3,034,000
+1.5%
41,118
-0.7%
0.04%
+2.7%
Q4 2021$2,989,000
-3.4%
41,394
+2.5%
0.04%
-9.8%
Q3 2021$3,094,000
+0.9%
40,377
+2.1%
0.04%
-2.4%
Q2 2021$3,065,000
+26.3%
39,539
+0.5%
0.04%
+16.7%
Q1 2021$2,426,000
+0.5%
39,338
+6.3%
0.04%
-10.0%
Q4 2020$2,413,000
+33.8%
37,005
+1.6%
0.04%
+21.2%
Q3 2020$1,804,000
+2.7%
36,421
-1.0%
0.03%
-8.3%
Q2 2020$1,756,000
+9.3%
36,807
-2.6%
0.04%0.0%
Q1 2020$1,607,000
-35.8%
37,796
-11.2%
0.04%
-23.4%
Q4 2019$2,505,000
+15.5%
42,547
+0.3%
0.05%
+9.3%
Q3 2019$2,169,000
+21.2%
42,431
+0.3%
0.04%
+16.2%
Q2 2019$1,789,000
+3.9%
42,310
+21.3%
0.04%0.0%
Q1 2019$1,722,000
+18.8%
34,869
+4.0%
0.04%
+5.7%
Q4 2018$1,450,000
-35.5%
33,523
-15.4%
0.04%
-30.0%
Q3 2018$2,247,00039,6030.05%
Other shareholders
GLOBUS MED INC shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 908,953$59,282,0005.54%
Sterling Investment Advisors, Ltd. 234,623$15,302,0005.20%
Next Capital Management LLC 111,098$7,246,0005.10%
Godshalk Welsh Capital Management, Inc. 77,085$5,027,0003.71%
Pembroke Management, LTD 613,931$40,041,0003.36%
XXEC, Inc. 52,800$3,444,0002.71%
Global Alpha Capital Management Ltd. 302,377$19,721,0002.42%
Van Berkom & Associates Inc. 1,572,303$102,546,0002.35%
PARADIGM CAPITAL MANAGEMENT INC/NY 581,700$37,939,0002.27%
RTW INVESTMENTS, LP 1,640,859$107,017,0001.80%
View complete list of GLOBUS MED INC shareholders